Synthetic Oligonucleotides in SPECT/CT In Vivo Imaging: Chemical Modifications, In111 Complex Formation, Incorporation into Drug Delivery Systems
Publisher
Springer New York
Reference8 articles.
1. Ma DDF, Rede T, Naqvi NA, Cook PD (2000) Synthetic oligonucleotides as therapeutics: the coming of age. Biotechnology 5:155–196
2. Geary RS, Norris D, Yu R, Bennett CF (2015) Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides. Adv Drug Deliv Rev 87:46–51
3. Park J, Park J, Pei Y, Xu J, Yeo Y (2016) Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines. Adv Drug Deliv Rev 104:93–109
4. Ming X, Laing B (2015) Bioconjugates for targeted delivery of therapeutic oligonucleotides. Adv Drug Deliv Rev 87:81–89
5. Otto P (1989) Investigation of the stability of oligonucleotides and polynucleotides. J Mol Struct THEOCHEM 188(3–4):277–288